TY - JOUR
T1 - Optical Coherence Tomography and Optical Coherence Domain Reflectometry for Deep Brain Stimulation probe guidance
AU - Jeon, Sung W.
AU - Shure, Mark A.
AU - Baker, Ken B.
AU - Chahlavi, Ali
AU - Hatoum, Nagi
AU - Turbay, Massud
AU - Rollins, Andrew M.
AU - Rezai, Ali R.
AU - Huang, David
PY - 2005/8/16
Y1 - 2005/8/16
N2 - Deep Brain Stimulation (DBS) is FDA-approved for the treatment of Parkinson's disease and essential tremor. Currently, placement of DBS leads is guided through a combination of anatomical targeting and intraoperative microelectrode recordings. The physiological mapping process requires several hours, and each pass of the microelectrode into the brain increases the risk of hemorrhage. Optical Coherence Domain Reflectometry (OCDR) in combination with current methodologies could reduce surgical time and increase accuracy and safety by providing data on structures some distance ahead of the probe. For this preliminary study, we scanned a rat brain in vitro using polarization-insensitive Optical Coherence Tomography (OCT). For accurate measurement of intensity and attenuation, polarization effects arising from tissue birefringence are removed by polarization diversity detection. A fresh rat brain was sectioned along the coronal plane and immersed in a 5 mm cuvette with saline solution. OCT images from a 1294 nm light source showed depth profiles up to 2 mm. Light intensity and attenuation rate distinguished various tissue structures such as hippocampus, cortex, external capsule, internal capsule, and optic tract. Attenuation coefficient is determined by linear fitting of the single scattering regime in averaged A-scans where Beer's law is applicable. Histology showed very good correlation with OCT images. From the preliminary study using OCT, we conclude that OCDR is a promising approach for guiding DBS probe placement.
AB - Deep Brain Stimulation (DBS) is FDA-approved for the treatment of Parkinson's disease and essential tremor. Currently, placement of DBS leads is guided through a combination of anatomical targeting and intraoperative microelectrode recordings. The physiological mapping process requires several hours, and each pass of the microelectrode into the brain increases the risk of hemorrhage. Optical Coherence Domain Reflectometry (OCDR) in combination with current methodologies could reduce surgical time and increase accuracy and safety by providing data on structures some distance ahead of the probe. For this preliminary study, we scanned a rat brain in vitro using polarization-insensitive Optical Coherence Tomography (OCT). For accurate measurement of intensity and attenuation, polarization effects arising from tissue birefringence are removed by polarization diversity detection. A fresh rat brain was sectioned along the coronal plane and immersed in a 5 mm cuvette with saline solution. OCT images from a 1294 nm light source showed depth profiles up to 2 mm. Light intensity and attenuation rate distinguished various tissue structures such as hippocampus, cortex, external capsule, internal capsule, and optic tract. Attenuation coefficient is determined by linear fitting of the single scattering regime in averaged A-scans where Beer's law is applicable. Histology showed very good correlation with OCT images. From the preliminary study using OCT, we conclude that OCDR is a promising approach for guiding DBS probe placement.
KW - Brain probe
KW - Deep Brain Stimulation
KW - Optical Coherence Domain Reflectometry
KW - Optical Coherence Tomography
KW - Polarization diversity detection
KW - Polarization insensitive measurement
KW - Rat brain
UR - http://www.scopus.com/inward/record.url?scp=23244464265&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23244464265&partnerID=8YFLogxK
U2 - 10.1117/12.591159
DO - 10.1117/12.591159
M3 - Conference article
AN - SCOPUS:23244464265
SN - 1605-7422
VL - 5686
SP - 487
EP - 494
JO - Progress in Biomedical Optics and Imaging - Proceedings of SPIE
JF - Progress in Biomedical Optics and Imaging - Proceedings of SPIE
M1 - 104
T2 - Photonic Therapeutics and Diagnostics
Y2 - 22 January 2005 through 25 January 2005
ER -